Uncatalyzed sigmatropic rearrangement of tyrosine-based compounds

    公开(公告)号:US10023527B2

    公开(公告)日:2018-07-17

    申请号:US15487116

    申请日:2017-04-13

    IPC分类号: C07C231/12

    摘要: A method for producing a compound of formula (I) or a pharmaceutically acceptable salt, solvate, tautomer or stereoisomer, such as compound 1 and compound 2 is disclosed. The method proceeds through an O-allylated tyrosine-based compound, such as compound 3 and preferably comprises [3,3] sigmatropic Claisen rearrangement and olefin cross metathesis reactions. In addition, a pharmaceutical composition comprising a compound of formula (I) a tumor necrosis factor (TNF) related apoptosis inducing ligand (TRAIL) and a pharmaceutically acceptable carrier or excipient is disclosed.